PRAME and melanoma: Other peptides of interest included peptides previously reported as immunogenic and derived from PReferentially expressed Antigen in MElanoma (PRAME), Melanoma associated antigen A1 (MAGEA1), and Ephrin receptors proteins (Table 1, Figure 2D).